These results suggest that stimulation of DNA replication origin assembly by SSRP1 during development does not cause significant DNA damage and is therefore compatible with ongoing transcription, consistent also with the normal morphology of fast developing embryos injected with SSRP1 or NTD. This evidence concerns the gene SSRP1 and neural tube defect.